UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016874
Receipt No. R000019585
Scientific Title Phase1/2study evaluating safety and efficacy of bortezomib-lenalidomid-dexamethasone induction therapy followed by lenalidomide-dexamethasone consolidation and lenalidomide maintenance for newly diagnosed patients with multiple myeloma eligible for stem cell transplantation.
Date of disclosure of the study information 2015/03/23
Last modified on 2018/06/01 15:23:30

No. Disposal Last modified on Item of update
1 Insert 2015/03/23 02:23:18
2 Update 2015/03/23 13:26:11 Email1
3 Update 2015/10/23 16:27:58 Recruitment status
4 Update 2018/06/01 15:23:30 Name of primary sponsor
Organization


Contact us.